Literature DB >> 3659543

Increased plasma volume in two models of portal hypertension in the rat: cirrhosis of the liver and partial portal vein ligation.

D Kravetz1, M T Arderiu, J Bosch, C Piera, J Setoain, J Rodés.   

Abstract

Portal hypertension has been studied in the rat to see if it is associated to altered blood volume composition, as it has been shown in other species. Plasma volume was measured by isotope dilution using 99mTc labelled albumin in three groups of male Sprague-Dawley rats: normal rats (controls), partially ligated portal vein rats and rats with Cl4C induced cirrhosis. Plasma volume was significantly higher in rats with portal hypertension due to partially ligated portal vein and cirrhosis than in control animals. Similarly, the calculated blood volume was also significantly higher in the portal hypertensive animals than in control group. Portal hypertension in the rat, therefore, has been demonstrated to be associated to a marked hypervolemia and this finding should be taken into consideration in haemodynamic and pharmacokinetic studies in portal hypertensive rat models.

Entities:  

Mesh:

Year:  1987        PMID: 3659543

Source DB:  PubMed          Journal:  Rev Esp Fisiol        ISSN: 0034-9402


  3 in total

1.  Acute effects of the anti-inflammatory cyclooxygenase-2 selective inhibitor, flosulide, on renal plasma flow and glomerular filtration rate in rats.

Authors:  A Turull; C Piera; J Queralt
Journal:  Inflammation       Date:  2001-04       Impact factor: 4.092

2.  Acute normovolaemic anaemia prevents ethanol-induced gastric damage in rats through a blood flow related mechanism.

Authors:  M Casadevall; J M Piqué; I Cirera; M D Barrachina; J Terés
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-11       Impact factor: 3.000

3.  Effects of chronic normovolemic anemia on gastric microcirculation and ethanol-induced gastric damage in rats.

Authors:  N Marroni; M Casadevall; J Panés; C Piera; J M Jou; J M Pique
Journal:  Dig Dis Sci       Date:  1994-04       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.